Bone health and osteoporosis research

Osteoporosis is a skeletal disease in which bones lose mineral density and their internal microstructure deteriorates, making fractures far more likely from falls or even minor stress. Researchers study how bone constantly remodels itself through the interplay of cells that build and break down tissue, and how signaling molecules like sclerostin and parathyroid hormone regulate that balance — insights that have already produced drugs such as denosumab and zoledronic acid capable of meaningfully reducing fracture risk. A central open question is how to better predict which individuals will fracture before they do, since standard bone density scans often miss people at risk by failing to capture the full complexity of bone's three-dimensional structure. Active work is also focused on optimizing treatment sequences and durations, particularly how to transition patients between different drug classes without triggering the rebound bone loss that can follow some therapies.

Works

103,295

Total citations

2,311,782

Keywords

FracturesBone Mineral DensityOsteoporotic FracturesMicrostructureDenosumabZoledronic Acid